Global Thalassemia Market DataPack (2016-2020)
The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research.
The market figures and industry dynamics are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.
It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers.
It also explores the competitive landscape of the respective market with focus on major players.
The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.
Our success parameter is very simple - impact of our services on our clients' business. We provide high quality, cost effective research and analysis to support decision making processes for industry professionals. Our strength lies in the reliability of our research and on the value added analysis that we provide.
We have a team of research analysts who have mastered the skill of preparing flawless market intelligence reports to help clients maximize their productivity and return on investment. Our analysts have great expertise to assess current trends in business practices, product promotion and market competition.
The market figures and industry dynamics are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.
It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers.
It also explores the competitive landscape of the respective market with focus on major players.
The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.
Our success parameter is very simple - impact of our services on our clients' business. We provide high quality, cost effective research and analysis to support decision making processes for industry professionals. Our strength lies in the reliability of our research and on the value added analysis that we provide.
We have a team of research analysts who have mastered the skill of preparing flawless market intelligence reports to help clients maximize their productivity and return on investment. Our analysts have great expertise to assess current trends in business practices, product promotion and market competition.
Global Thalassemia Incidence by Severity (2015E)
Global Thalassemia Diagnosis by Category (2015E)
Global Transfusion-Dependent β Thalassemia by Region (2015E)
Global Bone Marrow Transplant Revenue (2015E-2020F)
Global LentiGlobin BB305 Revenue (2018F-2025F)
Global Luspatercept Revenue (2018F-2022F)
The US β Thalassemia Carrier Patients – Actual (2014-2015E)
The US β Thalassemia Carrier Patients – Forecast (2016F-2020F)
The US β Thalassemia Major Patients – Actuals (2014-2015E)
The US β Thalassemia Major Patients – Forecast (2016F-2020F)
The US Transfusion-Dependent β Thalassemia Patients – Actuals (2014-2015E)
The US Transfusion-Dependent β Thalassemia Patients – Forecast (2016F-2020F)
The US β Thalassemia Sibling-Matched Stem Cell Transplant – Actuals (2014-2015E)
The US β Thalassemia Sibling-Matched Stem Cell Transplant – Forecast (2016F-2020F)
Europe Transfusion-Dependent β Thalassemia Patients (2015E-2020F)
Europe Transfusion-Dependent β-Thalassemia Major/Intermediate Patients (2015E-2020F)
Global Healthcare Expenditure (2010-2015E)
Spending on Stem Cell Research in the US (2013-2016F)
Population in East-Asia and Pacific (2010-2015E)
Revenue Comparison of the Global Key Players (2015)
Gross Profit Margin of the Global Key Players (2015)
Market Capitalization of the Global Key Players (2015)
Revenue Comparison of Key Players of the US (2015)
Revenue Share by Business Segments, Lonza Group (2015)
Revenue and Net Income, Lonza Group (2011-2015)
Revenue and Net Income, Bluebird Bio (2011-2015)
Revenue and Net Income, Acceleron Pharma (2011-2015)
Revenue and Net Income, Sangamo Biosciences (2011-2015)
Product Pipeline of Emerging Players (2015)
Product Pipeline, Bluebird Bio (2015)
Product Pipeline, Acceleron Pharma (2015)
Product Pipeline, Sangamo Biosciences (2015)
Global Thalassemia Diagnosis by Category (2015E)
Global Transfusion-Dependent β Thalassemia by Region (2015E)
Global Bone Marrow Transplant Revenue (2015E-2020F)
Global LentiGlobin BB305 Revenue (2018F-2025F)
Global Luspatercept Revenue (2018F-2022F)
The US β Thalassemia Carrier Patients – Actual (2014-2015E)
The US β Thalassemia Carrier Patients – Forecast (2016F-2020F)
The US β Thalassemia Major Patients – Actuals (2014-2015E)
The US β Thalassemia Major Patients – Forecast (2016F-2020F)
The US Transfusion-Dependent β Thalassemia Patients – Actuals (2014-2015E)
The US Transfusion-Dependent β Thalassemia Patients – Forecast (2016F-2020F)
The US β Thalassemia Sibling-Matched Stem Cell Transplant – Actuals (2014-2015E)
The US β Thalassemia Sibling-Matched Stem Cell Transplant – Forecast (2016F-2020F)
Europe Transfusion-Dependent β Thalassemia Patients (2015E-2020F)
Europe Transfusion-Dependent β-Thalassemia Major/Intermediate Patients (2015E-2020F)
Global Healthcare Expenditure (2010-2015E)
Spending on Stem Cell Research in the US (2013-2016F)
Population in East-Asia and Pacific (2010-2015E)
Revenue Comparison of the Global Key Players (2015)
Gross Profit Margin of the Global Key Players (2015)
Market Capitalization of the Global Key Players (2015)
Revenue Comparison of Key Players of the US (2015)
Revenue Share by Business Segments, Lonza Group (2015)
Revenue and Net Income, Lonza Group (2011-2015)
Revenue and Net Income, Bluebird Bio (2011-2015)
Revenue and Net Income, Acceleron Pharma (2011-2015)
Revenue and Net Income, Sangamo Biosciences (2011-2015)
Product Pipeline of Emerging Players (2015)
Product Pipeline, Bluebird Bio (2015)
Product Pipeline, Acceleron Pharma (2015)
Product Pipeline, Sangamo Biosciences (2015)
